Reduction of infarct size in a rat model of regional myocardial ischemia and reperfusion by the synthetic peptide DAHK
Authors:
- Michelle C. McDonaldMMMichelle C. McDonald
- Christoph ThiemermannCTChristoph Thiemermann
- 1 July 2006
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 34 (7) , 1955-1959
Abstract
The increased mobilization of iron and copper during ischemia is reported to contribute to postischemic injury. DMI-4983 is a small synthetic peptide, Asp-Ala-His-Lys (DAHK), that mimics the high-affinity copper-binding site of the N-terminus of human albumin. This peptide was reported to inhibit copper-induced formation of reactive oxygen species in vitro, reduce interleukin-8 formation in cultured endothelial cells, and improve left ventricular function after global ischemia and reperfusion in the isolated blood-perfused heart of the rat. The aim of this study was to investigate the effects of DMI-4983 on myocardial infarct size caused by regional ischemia and reperfusion in vivo. Rats were subjected to regional myocardial ischemia (25 mins) followed by reperfusion (2 hrs). Randomized groups received either vehicle or DMI-4983 administered as a 5, 10, or 20 mg/kg intravenous bolus along with a 10 mg/kg/hr continuous infusion starting just before reperfusion and continuing throughout the experiment. Infarct size was determined at the end of the experiment. Basic research institute and trauma research laboratory. Anesthetized male Wistar rats. The area at risk of infarction and hemodynamic variables were similar in all groups. Rats treated with vehicle resulted in an infarct size of 64% +/- 3% of the area at risk of infarction. Intravenous administration of DMI-4983 reduced infarct size to 52% +/- 3%, 50% +/- 2%, and 45% +/- 3% of the area at risk of infarction for 5, 10, and 20 mg/kg, respectively (p < .05 compared with vehicle for each dosage). Intravenous DMI-4983 administered before the onset of reperfusion and continuously throughout the reperfusion period caused a significant reduction in tissue necrosis in this in vivo model of regional myocardial ischemia and reperfusion, suggesting that DMI-4983 may represent a novel approach for the treatment of myocardial ischemia and reperfusion injury.Keywords
This publication has 12 references indexed in Scilit:
- Copper Stimulates the Synthesis and Release of Interleukin-8 in Human Endothelial Cells: A Possible Early Role in Systemic Inflammatory ResponsesShock, 2003
- Copper-induced oxidation of epinephrine: protective effect of d-DAHK, a synthetic analogue of the high affinity copper binding site of human albuminBiochemical and Biophysical Research Communications, 2003
- Dismutating the superoxide ion in sepsis *Critical Care Medicine, 2003
- Attenuation of Trace Element–Mediated Injury During Ischemia and Reperfusion by an N-Terminus Analogue of Human Albumin (H4DUS60131)Journal of Cardiovascular Pharmacology, 2002
- An Analog of the Human Albumin N-Terminus (Asp-Ala-His-Lys) Prevents Formation of Copper-Induced Reactive Oxygen SpeciesBiochemical and Biophysical Research Communications, 2001
- Asp-Ala-His-Lys (DAHK) Inhibits Copper-Induced Oxidative DNA Double Strand Breaks and Telomere ShorteningBiochemical and Biophysical Research Communications, 2001
- Characterization of the Co2+ and Ni2+ binding amino‐acid residues of the N‐terminus of human albuminEuropean Journal of Biochemistry, 2001
- Patterns of Mobilization of Copper and Iron Following Myocardial Ischemia: Possible Predictive Criteria for Tissue InjuryJournal of Molecular and Cellular Cardiology, 1997
- Reperfusion injury and its pharmacologic modification.Circulation, 1989
- Post resuscitation iron delocalization and malondialdehyde production in the brain following prolonged cardiac arrestJournal of Free Radicals in Biology & Medicine, 1985